Anna Marie Fulton, ARNP | |
3911 Castlevale Rd, Suite 301, Yakima, WA 98902-7807 | |
(509) 453-8231 | |
(509) 453-0130 |
Full Name | Anna Marie Fulton |
---|---|
Gender | Female |
Speciality | Obstetrics & Gynecology |
Location | 3911 Castlevale Rd, Yakima, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1992879860 | NPI | - | NPPES |
9629932 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | AP30005660 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Anna Marie Fulton, ARNP 3309 1st St, Union Gap, WA 98903-1820 Ph: (509) 453-8231 | Anna Marie Fulton, ARNP 3911 Castlevale Rd, Suite 301, Yakima, WA 98902-7807 Ph: (509) 453-8231 |
News Archive
Up to 80% of metastatic colorectal cancers are likely to have spread to distant locations in the body before the original tumor has exceeded the size of a poppy seed, according to a study of nearly 3,000 patients by researchers at the Stanford University School of Medicine.
A new editorial accompanying a study published in the Journal of the American College of Cardiology is bringing attention to the underappreciated and often overlooked issue of malnutrition among those who are obese.
Novartis Pharmaceuticals Corporation announced today that results from a Phase II study show Afinitor® (everolimus) tablets is the first medication in a clinical trial to decrease the size of subependymal giant cell astrocytomas (SEGAs), benign brain tumors associated with tuberous sclerosis (TS). In this study of 28 patients presented today at the 46th American Society of Clinical Oncology (ASCO) annual meeting in Chicago, 75% of patients experienced a reduction of 30% or greater in the size of their brain tumors from baseline to six months (p<0.001).
Investigators at Rutgers Cancer Institute of New Jersey have determined that an overabundance of a novel gene known as ADNP in an aggressive form of ovarian cancer may serve as a prognostic tool.
Halozyme Therapeutics, Inc. today announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®.
› Verified 2 days ago
Daniel Nicoara, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2205 W Lincoln Ave, Yakima, WA 98902 Phone: 509-469-6305 Fax: 509-575-3398 | |
Norman J Naiden, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2205 W Lincoln Ave, Yakima, WA 98902 Phone: 590-575-1234 Fax: 509-575-3320 | |
Deepika Kaushal, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2205 W Lincoln Ave, Yakima, WA 98902 Phone: 509-469-6305 Fax: 509-575-3398 | |
Judith A Hargis, PA Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3911 Castlevale Rd, Suite 301, Yakima, WA 98902 Phone: 509-453-8231 Fax: 509-453-0130 | |
Jonathan P Johns, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3003 Tieton Dr, Suite 200, Yakima, WA 98902 Phone: 509-454-2229 Fax: 509-454-7979 | |
Carly Mikela Ingalls, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3003 Tieton Dr Ste 230, Yakima, WA 98902 Phone: 509-248-3440 Fax: 509-249-4460 | |
Elizabeth Jacobson, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2205 W Lincoln Ave, Yakima, WA 98902 Phone: 509-496-6305 Fax: 509-575-3398 |